Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
dexamethasone injection
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
News
Trials
Company:
Generic mfg.
Drug class:
Steroid receptor agonist, GCR agonist
Related drugs:
‹
prednisone (24)
dexamethasone (18)
dexamethasone tablets (1)
dexamethasone acetate high-dose (0)
methylprednisolone acetate (0)
methylprednisolone oral (0)
methylprednisolone sodium succinate (0)
prednisolone (0)
prednisone (24)
dexamethasone (18)
dexamethasone tablets (1)
dexamethasone acetate high-dose (0)
methylprednisolone acetate (0)
methylprednisolone oral (0)
methylprednisolone sodium succinate (0)
prednisolone (0)
›
Associations
News
Trials
Filter by
Latest
5d
Verification of the Efficacy/Safety of the Mixed Drug Injectable Delivery Vehicle for Treating Intractable Hearing Loss (clinicaltrials.gov)
P1/2, N=26, Not yet recruiting, Seoul National University Hospital | Trial primary completion date: Feb 2026 --> Dec 2026
5 days ago
Trial primary completion date
|
dexamethasone • dexamethasone injection
5d
FLOW: Full-course Immunotherapy Combined With Chemotherapy in Newly Diagnosed B-cell Acute Lymphoblastic Leukemia (clinicaltrials.gov)
P2, N=101, Recruiting, The First Affiliated Hospital of Soochow University
5 days ago
New P2 trial
|
CD19 (CD19 Molecule)
|
cytarabine • doxorubicin hydrochloride • cyclophosphamide • Blincyto (blinatumomab) • dexamethasone injection • vindesine
6d
IMROZ: A Study to Investigate the Clinical Benefit of Isatuximab in Combination With Bortezomib, Lenalidomide and Dexamethasone in Adults With Newly Diagnosed Multiple Myeloma Not Eligible for Transplant (clinicaltrials.gov)
P3, N=475, Active, not recruiting, Sanofi | Trial primary completion date: Apr 2026 --> Apr 2027
6 days ago
Trial primary completion date
|
lenalidomide • bortezomib • dexamethasone • Sarclisa (isatuximab-irfc) • dexamethasone injection
9d
QLS4131 Combination Therapy in Malignant Plasma Cell Neoplasms (clinicaltrials.gov)
P2, N=162, Not yet recruiting, Qilu Pharmaceutical Co., Ltd.
9 days ago
New P2 trial
|
lenalidomide • dexamethasone • pomalidomide • dexamethasone injection
10d
MANTRA: Multimodal Anesthesia in Robotic Laparoscopic Nephrectomy (clinicaltrials.gov)
P=N/A, N=80, Not yet recruiting, Fundacio Puigvert
10 days ago
New trial
|
dexamethasone injection • ondansetron intravenous
10d
An Exploratory Study on Efficacy and Safety of Fosaprepitant and Palonosetron Hydrochloride for Injection in Preventing CINV From Multi-Agent HEC (clinicaltrials.gov)
P4, N=200, Recruiting, Shanghai 6th People's Hospital | Not yet recruiting --> Recruiting
10 days ago
Enrollment open
|
dexamethasone injection • fosaprepitant • olanzapine
10d
IZALCO: A Study to Investigate Subcutaneous Isatuximab in Combination With Carfilzomib and Dexamethasone in Adult Participants With Relapsed and/or Refractory Multiple Myeloma (clinicaltrials.gov)
P2, N=118, Active, not recruiting, Sanofi | N=55 --> 118
10 days ago
Enrollment change
|
carfilzomib • dexamethasone • dexamethasone injection • isatuximab subcutaneous (SAR650984 SC)
10d
MonumenTAL-6: A Study Comparing Talquetamab Plus Pomalidomide, Talquetamab Plus Teclistamab, and Elotuzumab, Pomalidomide, and Dexamethasone or Pomalidomide, Bortezomib, and Dexamethasone in Participants With Relapsed or Refractory Myeloma Who Have Received an Anti-CD38 Antibody and Lenalidomide (clinicaltrials.gov)
P3, N=795, Recruiting, Janssen Research & Development, LLC | N=468 --> 795
10 days ago
Enrollment change
|
lenalidomide • bortezomib • pomalidomide • Empliciti (elotuzumab) • Talvey (talquetamab-tgvs) • Tecvayli (teclistamab-cqyv) • dexamethasone injection
11d
Dex & Mastectomy Pain (clinicaltrials.gov)
P4, N=170, Recruiting, McGill University Health Centre/Research Institute of the McGill University Health Centre
11 days ago
New P4 trial
|
dexamethasone injection
12d
SWOG-1211: S1211 Bortezomib, Dexamethasone, and Lenalidomide With or Without Elotuzumab in Treating Patients With Newly Diagnosed High-Risk Multiple Myeloma (clinicaltrials.gov)
P1/2, N=142, Completed, SWOG Cancer Research Network | Active, not recruiting --> Completed
12 days ago
Trial completion
|
SKY92 Test
|
lenalidomide • bortezomib • Empliciti (elotuzumab) • dexamethasone injection
16d
Effect of Intraoperative Dexamethasone on Early Postoperative Sleep Quality in Patients Undergoing Nasal Surgery (clinicaltrials.gov)
P=N/A, N=102, Not yet recruiting, Seoul National University Hospital
16 days ago
New trial
|
dexamethasone • dexamethasone injection
17d
The effect of intravenous combined application of dexamethasone and dexmedetomidine on postoperative rebound pain in patients with brachial plexus block: A randomized, double-blind, controlled trial (ChiCTR2600121570)
P=N/A, N=120, Taizhou Hospital of Zhejiang Province; Taizhou Hospital of Zhejiang Province
17 days ago
New trial
|
dexamethasone injection
Share via
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.